AI-driven platform designing multivalent nanoparticles with peptide binders for cell-selective non-viral gene therapy delivery.
Nanograb is a computational drug discovery company that uses generative AI to design nanoparticles that deliver genetic medicines to specific cells and tissues without viral vectors. Its platform combines small peptide binders attached to nanoparticles to create targeted non-viral gene therapy delivery systems, aiming to enable disease treatment without systemic side effects and at scale. The approach is designed to avoid the limitations and manufacturing challenges of traditional viral delivery vectors. Nanograb is a product of Nanograb.